How long is the duration of treatment for XDR-TB? At least 2 years (the same as MDR-TB). Doctors will monitor people with any form of confirmed drug resistant.

Slides:

Advertisements

Similar presentations

Ebola. What is Ebola?? Ebola is a rare and deadly disease caused by the infection of the Ebola Virus (5 strands) Ebola viruses are found in several African.

Advertisements

Why do we test? 1.We want to prevent an outbreak of Tuberculosis in our campus community 2.We want to find those that are affected and get them treated.

Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.

What is Tuberculosis (TB)? TB is a disease that primarily affects the lungs It is dangerous if you do not receive treatment!

Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital

Module 3: Drug-Resistant TB. Learning Objectives Describe how drug resistance emerges Explain the difference between primary and secondary resistance.

Southern New Hampshire Health System Southern New Hampshire Medical Center 188 bed acute care community hospital 2/3 market share in southern NH area.

HIV and AIDS. AIDS (Acquired immune deficiency syndrome)- a disease in which the immune system of the patient is weakened. HIV (Human immunodeficiency.

TB. Areas of Concern TB cases continue to be reported in every state Drug-resistant cases reported in almost every state Estimated million persons.

HIV-TB Model: The Botswana experience By E.M. Lungu (UB) M. Kgosimore (BCA) F. Nyabadza (UB) Modeling Disease in Africa Workshop 25 – 27 June 2007, Stellenbosch,

MDR and XDR TB Bruce A. Bush, M.D. Regional Tuberculosis Consultant

Tuberculosis (TB) Facts

Preventing HIV/AIDS There is no way to tell just by looking whether a person is infected with HIV. Because people are unaware that they are HIV-positive,

* TB is caused by a bacterium called Mycobacterium Tuberculosis. The bacteria usually attacks the lungs, but TB bacteria can attack any part of the.

2 New HIV diagnoses and number of persons accessing HIV care in the United Kingdom: 2014.

Tuberculosis Presented by Vivian Pham and Vivian Nguyen.

+ Tuberculosis: Quick Facts. + Tuberculosis: Reflection How does TB affect a person’s health? How does TB affect a person’s life, socially? What problem.

Adverse events in an integrated, home-based treatment program for MDR-TB & HIV in Tugela Ferry, South Africa JCM Brust*, NS Shah, TL van der Merwe, S Bamber,

MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.

Training Module 2: Respondent Eligibility Criteria.

Did you know?. About 9.5 million people die each year due to global infectious diseases. Most of them are in third world countries.

DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.

Antibiotic Resistant Bacteria Kia Witt. Why are Bacteria Becoming Antibiotic Resistant? Doctors liberally prescribe antibiotics, often for infections.

Multi-drug resistant tuberculosis: Progress and challenges in South Africa Dr S. Moyo HIV/AIDS, Sexually Transmitted Infections and TB research (HAST)Programme.

Palliative care and pain treatment in Zithulele Hospital and surrounding area 30 September 2011 Annette Dekker Health Grand Challenge Summer of Learning.

Tuberculosis in Ealing - Housing. What is TB Tuberculosis, or TB, is a disease caused by a germ (Mycobacterium tuberculosis). TB usually affects the lungs,

NOTIFIED TUBERCULOSIS CASES IN LITHUANIA New cases and relapses (abs.n.)

A decentralized model of care for drug-resistant tuberculosis in a high HIV prevalence setting Cheryl McDermid, Helen Cox, Simiso Sokhela, Gilles van Cutsem,

PREVENTING RELAPSE Lee B. Reichman, MD, MPH Northeast TB Controllers Meeting October 24, 2006 Princeton, New Jersey.

Tuberculosis Research of INA-RESPOND on Drug-resistant

XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps…

Programmatic Management of Multidrug Resistant TB (PMDT) 5 th Joint International Monitoring Mission of NTP, Thailand 23 August, 2013.

Max O’Donnell, Nesri Padayatchi, Iqubal Master, Garth Osburn, Robert Horsburgh Treatment of Extensively Drug Resistant Tuberculosis Among Patients with.

Devin schonewolf Biology 2 mcgarvey

Tuberculosis What is tuberculosis?.

Office of Overseas Programming & Training Support (OPATS) Treatment Adherence HIV Care, Support, and Treatment.

TB/HIV management survey  Baseline audit in parallel with guidelines development process  Survey of clinician opinion and practice  Data collection.

HEPATITIS MOBILE TEAM News Tools of screening viral hepatitis in real life: the french model of care André-Jean REMY (1,2), Hugues WENGER (1), Hakim BOUCKHIRA.

Screening for TB.

International Health Policy Program -Thailand Policy decision on multi drug resistant(MDR), extreme drug resistant(XDR) tuberculosis screening: How it.

HIV and AIDS By Lindsey Wilderotter. What is HIV/AIDS? HIV is a virus and therefore the pathogen that attacks the immune system and also known as a retrovirus.

Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.

TB, MDR-TB and XDR-TB in South Africa October 2006.

Public Health. TB-DOTS program Government commitment Case detection by DSSM among symptomatic patients self-reporting to health services Standard short-course.

TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.

HIV and AIDS By Lindsey Wilderotter. What is HIV/AIDS? HIV is a virus and therefore the pathogen that attacks the immune system and also known as a retrovirus.

1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 7: GAP BETWEEN AVAILABILTY OF DRUG SUSCEPTIBILITY.

By: Kristen Sieck and Scott Senftner 3rd Period Health Class

Population and Health Infectious and Lifestyle Diseases.

The Future of Drug-Resistant TB: How Do We Prevent a Nightmare? (HINT: By Treating It!) David Dowdy, MD PhD B. Frank Polk Assistant Professor of Epidemiology.

L.A. County Public Health Partnering with the Private Community to Control TB Myrna Mesrobian, MD, MPH.

Antimicrobial resistance

1 Adherence to ARV Therapy and Resistance HAIVN Havard Medical School AIDS Initiative in Vietnam.

Introduction of outpatient care for DS-/MDR-TB patients in Tajikistan Cape Town, December 02-06, 2015.

Dan Dougherty and Allie Capetola Period 5.  Human immunodeficiency virus  Leads to AIDS (Acquired immunodeficiency syndrome)  HIV is spread through.

 1 finger = Don’t know, never heard of it  2 fingers = Heard it before but I don’t know it  3 fingers = I know this word  Genetic  Blueprint  Genes.

Antibiotic Resistance By Willy. What is Antibiotic Resistance? Antibiotic Resistance is a microorganism that is able to withstand the effects of antibiotics.

James R. Ginder, MS, WEMT,PI, CHES Health Education Specialist Jeremy D. Hamilton Health Education Intern Hamilton County Health Department

Mycobacterium tuberculosis Klebsiella pneumoniae, Legionella pneumophila, Mycobacterium leprae.

Lesson 4 Do you think HIV is a curable disease? Treatment for HIV and AIDS Even though medicines can slow the progress of HIV infection, there is still.

Global Tuberculosis Control 2007 Did we reach the 2005 targets? Will we achieve the Millennium Development Goals?

Liver cancer treatment India. Liver Cancer treatment The meaning of the liver cancer is the condition where abnormal cell division gives rise to the development.

PMDT IN CHINESE TAIPEI ECONOMY Anita Pei-Chun Chan, MD, PhD Medical Officer, TCDC Associated Director, TB Research Center, TCDC Assistant Professor, Institute.

Where Are We on the Path to Elimination of Chronic Hepatitis C?

The Respiratory System

What Are Clinical Trials?

Devin schonewolf Biology 2 mcgarvey

Do you think medicals robots are helpful?

7C52 Miracle Drugs.

Preventing and Treating STDs (2:29)

Presentation transcript:

How long is the duration of treatment for XDR-TB? At least 2 years (the same as MDR-TB). Doctors will monitor people with any form of confirmed drug resistant TB very carefully. Treatment will continue for as long as it takes for the patient to be cured, if that patient CAN be cured. Because it is so difficult to treat, many people who get drug-resistant TB will not survive.

Drug-resistant TB should ALWAYS be managed by - or in close consultation with - a MEDICAL EXPERT in the disease. Fortunately, XDR-TB is still a very rare disease in South Africa – we need to try and keep it that way!

If a person is diagnosed with MDR-TB, does he/she have to be admitted to hospital? It depends on the ‘severity of the disease’... An MDR-TB patient does not have to go to hospital if the following apply: He/she can walk and is in a fair to good general condition. He/she is unlikely to spread the disease to other people (is ‘smear negative’). He/she refuses admission or beds are not available in the hospital. He/she has access to stable accommodation (is not homeless) There is someone at home or in the community who will provide treatment support. A patient who refuses to be admitted to hospital will have to have a very good reason why they do not want to go.

If a person is diagnosed with XDR-TB, does he/she have to be admitted to hospital? Yes! For how long? It depends on how the person responds to treatment. The doctors may have to try different combinations of injections and tables to see which mixture of treatment works best for an individual patient. Treatment will continue for as long as it takes for the patient to be cured, if that patient CAN be cured.

Can an apple seed turn into an apple tree? Why???

Can an apple seed turn into a Protea? Why???

Can an HIV virus turn into a TB mycobacteria? Why???

Can a TB mycobacteria turn into an HIV virus? Why???